View in EDS

Correction: Regulatory Considerations Toward Orphan Drug Designation and Orphan Drug Exclusivity in the United States and European Union: Structural Similarity, Clinical Superiority/Significant Benefit, and Case Studies.

Saved in:
Bibliographic Details
Title: Correction: Regulatory Considerations Toward Orphan Drug Designation and Orphan Drug Exclusivity in the United States and European Union: Structural Similarity, Clinical Superiority/Significant Benefit, and Case Studies.
Authors: Roberts SW; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark. osrb@novonordisk.com., Elvang TLB; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Syed L; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Samuelsen MB; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Arp-Hansen EL; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Nielsen HK; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Lund IK; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Dünweber DL; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Listov-Saabye N; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Bjørn-Larsen D; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Hjelmsmark A; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark., Mikkelsen TA; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.
Source: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2023 Mar; Vol. 57 (2), pp. 396-398.
Publication Type: Published Erratum
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print Cited Medium: Internet ISSN: 2168-4804 (Electronic) Linking ISSN: 21684790 NLM ISO Abbreviation: Ther Innov Regul Sci Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36472778
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Correction: Regulatory Considerations Toward Orphan Drug Designation and Orphan Drug Exclusivity in the United States and European Union: Structural Similarity, Clinical Superiority/Significant Benefit, and Case Studies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Roberts+SW%22">Roberts SW</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark. osrb@novonordisk.com.<br /><searchLink fieldCode="AU" term="%22Elvang+TLB%22">Elvang TLB</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Syed+L%22">Syed L</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Samuelsen+MB%22">Samuelsen MB</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Arp-Hansen+EL%22">Arp-Hansen EL</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Nielsen+HK%22">Nielsen HK</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Lund+IK%22">Lund IK</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Dünweber+DL%22">Dünweber DL</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Listov-Saabye+N%22">Listov-Saabye N</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Bjørn-Larsen+D%22">Bjørn-Larsen D</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Hjelmsmark+A%22">Hjelmsmark A</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Mikkelsen+TA%22">Mikkelsen TA</searchLink>; Regulatory Affairs, Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101597411%22">Therapeutic innovation & regulatory science</searchLink> [Ther Innov Regul Sci] 2023 Mar; Vol. 57 (2), pp. 396-398.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing%22">Springer International Publishing </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101597411 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221684790%22">21684790 </searchLink><i>NLM ISO Abbreviation: </i>Ther Innov Regul Sci <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36472778
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s43441-022-00487-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 396
    Titles:
      – TitleFull: Correction: Regulatory Considerations Toward Orphan Drug Designation and Orphan Drug Exclusivity in the United States and European Union: Structural Similarity, Clinical Superiority/Significant Benefit, and Case Studies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roberts SW
      – PersonEntity:
          Name:
            NameFull: Elvang TLB
      – PersonEntity:
          Name:
            NameFull: Syed L
      – PersonEntity:
          Name:
            NameFull: Samuelsen MB
      – PersonEntity:
          Name:
            NameFull: Arp-Hansen EL
      – PersonEntity:
          Name:
            NameFull: Nielsen HK
      – PersonEntity:
          Name:
            NameFull: Lund IK
      – PersonEntity:
          Name:
            NameFull: Dünweber DL
      – PersonEntity:
          Name:
            NameFull: Listov-Saabye N
      – PersonEntity:
          Name:
            NameFull: Bjørn-Larsen D
      – PersonEntity:
          Name:
            NameFull: Hjelmsmark A
      – PersonEntity:
          Name:
            NameFull: Mikkelsen TA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2023 Mar
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2168-4804
          Numbering:
            – Type: volume
              Value: 57
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Therapeutic innovation & regulatory science
              Type: main
ResultId 1